FOR IMMEDIATE RELEASE

Phoenix, AZ – June 24, 2024 – SharpMed, LLC, a pioneer in innovative medical solutions, is thrilled to announce a strategic partnership with AMS Micromedical, a leading medical device manufacturer in the United States, to produce the groundbreaking Turbo® O₂ Cap. This device is designed to reduce or eliminate hypoxia during difficult intubations, marking a significant advancement in emergency medical technology. The commercial launch of the Turbo® O₂ Cap is anticipated in Q4 2024.

AMS Micromedical, renowned for its high precision engineering, CNC machining, and injection molding capabilities, will manufacture the Turbo® O₂ Cap at its state-of-the-art, 29,000-square-foot facility in Sparta, Wisconsin. This facility is ISO-certified and FDA-approved, ensuring the highest quality standards. Tom Arendt, the visionary founder of AMS, has cultivated an environment where engineers and medical device professionals collaborate to produce custom, ultra-precise, USA-made products.

“We are thrilled to partner with AMS Micromedical,” said Dr. Chris Salvino, President and Founder of SharpMed. “Their expertise and commitment to excellence will enable us to bring the Turbo® O₂ Cap to market efficiently and reliably. Both teams share a culture of innovation and collaboration, which is vital for advancing medical technology.”

The Turbo® O₂ Cap, protected by two issued patents and four pending, has demonstrated remarkable results in preclinical trials. Research has shown that in large animals whose breathing had stopped, the Turbo® O₂ Cap maintained oxygen levels above 97% for over 15 minutes. “These results are outstanding,” said Dr. Salvino. “The Turbo® O₂ Cap promises to be a game-changer in emergency and critical care settings.”

With this manufacturing agreement, SharpMed anticipates that the Turbo® O₂ Cap will be available for shipment to customers in Q4 of 2024. This partnership marks a significant step forward in SharpMed’s mission to enhance patient outcomes and revolutionize emergency medical care.

For more information about the Turbo® O₂ Cap and SharpMed, LLC, please contact:

Chris Salvino, MD
President and Founder
SharpMed, LLC
Email: info@sharpmed.com
Website: www.sharpmed.com

About SharpMed, LLC

SharpMed, LLC is a leading innovator in medical technology, dedicated to developing cutting-edge solutions to improve patient care and outcomes. Founded by Dr. Chris Salvino, SharpMed focuses on addressing critical challenges in emergency and critical care with innovative, patent-protected devices.

About AMS Micromedical

AMS Micromedical is a premier medical device manufacturer located in Sparta, Wisconsin. Founded by Tom Arendt, AMS specializes in high precision engineering, CNC machining, and injection molding, producing custom, ultra-precise, USA-made medical devices. The company’s ISO-certified and FDA-approved facility embodies a commitment to quality and innovation.

Note to Editors: High-resolution images and further information are available upon request.